My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Trent gets upgradation in rating of NCDs
Dec 23,2016

Trent announced that Brickwork Ratings has upgraded the rating for the Non-Convertible Debentures amounting to Rs. 75 crore issued by the Company which have been listed on National Stock Exchange of India , from BWR AA (Pronounced BWR Double A) (Outlook: Stable) to BWR AA+ (Pronounced BWR Double A Plus) (Outlook: Stable).

Powered by Capital Market - Live News

Thomas Scott India announces resignation of CFO
Dec 23,2016

Thomas Scott India announced that Abhay Kumar Singh, Chief Financial officer (KMP) of the company has resigned from his duties w.e.f. 10 December 2016 wherein the company has received his resignation letter on 23 December 2016.

Powered by Capital Market - Live News

Tata Metaliks gets High Court approval for scheme of amalgamation
Dec 23,2016

Tata Metaliks announced that Honble High Court, Calcutta has sanctioned the Scheme of amalgamation between Tata Metaliks DI Pipes and Tata Metaliks on 07 November 2016.

Powered by Capital Market - Live News

ARSS Infrastructure Projects wins road project worth Rs 164 crore
Dec 23,2016

ARSS Infrastructure Projects announced that a work order amounting to Rs.164.00 crore namely Widening of existing two lane to two lane with 1.5 mt wide paved shoulder from KM 50/0 to 140/9 of NH 57 on EPC Mode has been awarded in favour of the Company by Office of Chief Engineer, National Highways, Odisha, Bhubaneswar on 22 December 2016.

Powered by Capital Market - Live News

ARSS Infrastructure Projects secures road project in State of Odisha
Dec 23,2016

ARSS Infrastructure Projects announced that the Company has secured a work order amounting to Rs.164.50 crore namely Widening of existing 2 lane to 2 lane with 1.5 mt wide paved shoulder from KM 0/0 to 81/0 and Km. 83/0 to 119/0 of NH 157 in the State of Odisha on EPC Mode is awarded in favour of the Company by Office of Chief Engineer, National Highways, Odisha, Bhubaneswar on 22 December 2016.

Powered by Capital Market - Live News

Syncom Healthcare MD resigns
Dec 23,2016

Syncom Healthcare announced that Pratik Bankda, Managing Director and a Board Member of the Company has resigned with effect from 23 December 2016.

Powered by Capital Market - Live News

Cipla received final approval for Sereflon++
Dec 23,2016

Cipla has yielded a final approval for its lead MDI product Fluticasone + Salmeterol (Sereflon++) from UK MHRA for its partner in the UK.

Sereflon++, 25 mcg/125 mcg & 25 mcg/250 mcg are generic equivalent to GlaxoSmithKlines Seretiden++ Inhalers and are indicated for Asthma treatment.

Seretiden++ Inhaler, for the aforementioned strengths, had UK sales of approximately $278M for the 12 month period ending June 2016, according to IMS Health. Ciplas Sereflon++ will be launched in theUK through a partner in the coming weeks.

Powered by Capital Market - Live News

Supra Pacific Management Consultancy appoints directors
Dec 23,2016

Supra Pacific Management Consultancy announced that the Board of Directors of the Company have appointed Sharad Laxman Kulkarni and Nitin Sharad Phadke as Directors of the Company w.e.f. 23 December 2016.

Powered by Capital Market - Live News

Claris Lifesciences reverses recent fall on bargain hunting
Dec 23,2016

Meanwhile, the S&P BSE Sensex was up 61.10 points, or 0.24%, to 26,040.70

On the BSE, 2.78 lakh shares were traded on the counter so far as against the average daily volumes of 3.24 lakh shares in the past one quarter. The stock hit a high of Rs 333.60 and a low of Rs 315.50 so far during the day.

The stock hit a record high of Rs 430.10 on 16 December 2016. The stock hit a 52-week low of Rs 126.10 on 12 February 2016. The stock had outperformed the market over the past 30 days till 22 December 2016, rising 23.57% compared with the 0.28% fall in the Sensex. The scrip also outperformed the market in past one quarter, surging 40.88% as against Sensexs 9.38% decline.

The small-cap company has an equity capital of Rs 54.57 crore. Face value per share is Rs 10.

Claris Lifesciences consolidated net profit rose 169.92% to Rs 32.39 crore on 0.65% fall in net sales to Rs 192.13 crore in Q2 September 2016 over Q2 September 2015.

Claris Lifesciences is holding company of Claris Injectables, a wholly-owned subsidiary dealing in specialty injectables business. It is also the holding company of Claris Otsuka Private Limited, a joint venture with Japans Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co. for Infusion business in India and emerging markets.

Powered by Capital Market - Live News

Rudraksh Cap-Tech to be renamed Alexander Stamps & Coins
Dec 23,2016

Rudraksh Cap-Tech announced that the Company is being renamed Alexander Stamps & Coins which is already approved by Company Law Board and soon Stock Exchanges also would incorporate the same.

Powered by Capital Market - Live News

Godrej Consumer Products fixes record date for interim dividend
Dec 23,2016

Godrej Consumer Products has fixed 07 February 2017 as the Record Date as for the purpose of Payment of Interim Dividend for the financial year 2016-17.

The said interim dividend, if declared, will be paid on 21 February 2017.

Powered by Capital Market - Live News

Cipla gains after receiving UK MHRA approval for Sereflo
Dec 23,2016

The announcement was made during trading hours today, 23 December 2016.

Meanwhile, the BSE Sensex was up 57.91 points, or 0.22%, to 26,037.51.

On the BSE, so far 2.56 lakh shares were traded in the counter, compared with average daily volumes of 1.34 lakh shares in the past one quarter. The stock had hit a high of Rs 588.90 and a low of Rs 552.55 so far during the day.

The stock hit a 52-week high of Rs 660 on 29 December 2015. The stock hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past 30 days till 22 December 2016, rising 1.45% compared with the 0.28% fall in the Sensex. The scrip had also outperformed the market in past one quarter, falling 8.34% as against Sensexs 9.38% decline.

The large-cap company has equity capital of Rs 160.88 crore. Face value per share is Rs 2.

Cipla said it yielded a final approval for its lead MDI product Fluticasone + Salmeterol (Sereflo) from UK MHRA (UK Medicines and Healthcare products Regulatory Agency) for its partner in the UK. Sercflo, 25 mcg/125 mcg & 25 mcg/250 mcg are generic equivalent to GlaxoSmithKlines Seretide inhalers and are indicated for Asthma treatment.

Seretide Inhaler, for the aforementioned strengths, had UK sales of approximately $278 million for the 12 month period ending June 2016, according to IMS Health. Ciplas Sereflo will be launched in the UK through a partner in the coming weeks.

On a consolidated basis, Ciplas net profit dropped 34.75% to Rs 354.34 crore on 8.66% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally.

Powered by Capital Market - Live News

Centrum Capital hits 52-week high as promoters hike stake
Dec 23,2016

Meanwhile, the S&P BSE Sensex was up 50.05 points, or 0.19%, to 26,033.03

On the BSE, 5.84 lakh shares were traded on the counter so far as against the average daily volumes of 5.72 lakh shares in the past one quarter. The stock hit a high of Rs 32.60 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 30 so far during the day.

The stock hit a 52-week low of Rs 9.75 on 5 April 2016. The stock had outperformed the market over the past 30 days till 22 December 2016, rising 6.52% compared with the 0.28% fall in the Sensex. The scrip also outperformed the market in past one quarter, falling 1.01% as against Sensexs 9.38% decline.

The small-cap financial services firm has an equity capital of Rs 41.60 crore. Face value per share is Re 1.

Centrum Capital said that JBCG Advisory Services has acquired 1.95 crore equity shares representing 4.7% of total equity of the company at Rs 25.08 per share in a block deal on the BSE yesterday, 22 December 2016. Indivision India Partners was seller to the tune of 2.05 crore shares at Rs 25 per share. Promoters held 32.25% stake in Centrum Capital (as per the shareholding pattern as on 30 September 2016).

Centrum Capital is a Sebi registered category I merchant banker. It has expertise across equity & debt spectrum with capabilities in equity capital markets, M&A advisory, corporate finance & advisory, primary & secondary debt placement, project finance and corporate debt restructuring. Its retail arm provides integrated solutions for private wealth management, portfolio management, stock broking and foreign exchange.

Powered by Capital Market - Live News

Sugar shares spurt after rise in sugar prices
Dec 23,2016

Oudh Sugar Mills (up 12.22%), Dwarikesh Sugar Industries (up 10.86%), Upper Ganges Sugar & Industries (up 9.99%), Rana Sugars (up 8.57%), Sakthi Sugars (up 7.47%), Simbhaoli Sugars (up 7.16%), Triveni Engineering & Industries (up 5.88%), DCM Shriram Industries (up 4.17%), Dhampur Sugar Mills (up 3.22%), Empee Sugars and Chemicals (up 2.75%), Balrampur Chini Mills (up 2.63%), KCP Sugar & Industries Corporation (up 2.33%), Shree Renuka Sugar (up 0.68%) and Bajaj Hindusthan Sugar (up 0.21%), edged higher. EID Parry (India) was down 0.78%.

The S&P BSE Sensex was up 55.43 points, or 0.21% at 26,035.03.

Raw Sugar futures dropped under 18 cents per pound last week before bouncing back above that levels this week. Conab, the Brazilian crop supply agency has noted that sugar prices are being helped by concerns of a global production deficit.

This rebound has also capped the losses for local sugar prices, which took a hit after the Demonetization drive. Medium Grade Sugar in Muzaffarnagar dropped from Rs 3780 per quintal to Rs 3630 per quintal in six week after the government banned high values notes on 8 November 2016. However, prices are up near Rs 3700 per quintal now. The commodity is up about 15% this year.

Meanwhile, according to the Indian Sugar Mills Association (ISMA), as on 15 December 2016, 440 sugar mills were crushing sugarcane for the year 2016-2017 SS, and they have produced 53.29 lakh tonnes of sugar till that date, i.e. 5.36 lakh tonnes, or 11%, higher than the sugar production on the corresponding date of previous sugar season, when same number of sugar mills were in operation and had produced 47.93 lakh tonnes of sugar.

Powered by Capital Market - Live News

Foundation stone laying ceremony for first Second Generation Ethanol Bio-refinery on 25 Dec 2016
Dec 23,2016

The Foundation Stone laying ceremony for setting up the first Second Generation (2G) Ethanol Bio-refinery in India is being held on 25 December 2016 at village Tarkhanwala, Bathinda (Punjab), with an approximate investment of Rs 600 crore. Hindustan Petroleum Corporation (HPCL), a Central Government Public Sector Undertaking, is setting up the project.Minister of Food Processing Industries, Harsimarat Kaur Badal, Minister of State (I/C) Petroleum & Natural Gas, Dharmendra Pradhan, and Deputy Chief Minister of Punjab, Sukhbir Singh Badal shall jointly lay the Foundation Stone.The Government of India is encouraging production of Second Generation (2G) Ethanol from agricultural residues to provide additional sources of remuneration to farmers, address the growing environmental concerns and support the Ethanol Blended Petrol (EBP) programme for achieving 10% Ethanol Blending in Petrol.The Bathinda Bio-refinery will be utilizing agriculture residues for production of 100 KL per day or 3.20 crore litres per annum of ethanol which may be sufficient to meet the 26% of the ethanol blending requirement of the State. The proposed Bio-refinery will generate employment for about 1200 -1300 persons in the Biomass supply chain and generate an additional income of approximately Rs 20 crore per annum for the farmers through purchase of their agriculture residues. The project shall also help in reducing CO2 emissions from the paddy straw which currently is being burnt after harvesting.One of the major outputs of this Bio-refinery shall be Bio-fertilizer approximating 30,000 tonnes per annum which shall be incorporated into the soil for improving soil fertility and overall productivity of farms in Punjab. The Bio-refinery shall also produce more than 1.00 lakh Kg of Bio-CNG per annum which can cater to transport and clean cooking requirements.Oil PSUs, in line with vision laid down by Government of India, are planning to set up twelve (12) 2G Ethanol Bio-refineries across 11 States viz. Punjab, Haryana, U.P., M.P, Bihar, Assam, Odisha, Gujarat, Maharashtra, Karnataka and A.P. The estimated investment for the 12 Bio-refineries is Rs 10,000 crore. These Bio-refineries shall produce around 35- 40 crore litres of Ethanol annually, thus contributing significantly towards the EBP programme.Recently, in Petrotech-2016 on 07.12.2016, Oil PSUs also entered into 6 MoUs with Technology licensors and State Governments for setting up Bio-refineries in Dahej (Gujarat), Panipat (Haryana), Bina (MP), Bargarh (Odisha) and Bathinda (Punjab).The Bio-refinery at Bathinda is the first step towards achieving 10% blending of Ethanol in petrol. Similar 2G Bio-refineries at other places are expected to be started soon.

Powered by Capital Market - Live News